PTLA - Portola Pharmaceuticals EPS misses by $0.07 misses on revenue May, 11 2020 08:07 AM Portola Pharmaceuticals Inc. Portola Pharmaceuticals (NASDAQ:PTLA): Q1 GAAP EPS of -$0.88 misses by $0.07.More news on: Portola Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...